Research map: Cocrystal-enabled bilayer fixed-dose combination of empagliflozin and metformin: from solid-state design to clinical bioequivalence

Back to the article

Papers in this map

  1. A simple practice guide for dose conversion between animals and human · Anroop Balachandran Nair · 2016 · 6167 citations · Cited by this paper
  2. Dose optimization of omadacycline for the treatment of nontuberculous mycobacterial pulmonary disease (NTM-PD) using a physiologically based pharmacokinetic modeling approach · 2025 · Related
  3. Role of AMP-activated protein kinase in mechanism of metformin action · Gaochao Zhou · 2001 · 5475 citations · Cited by this paper
  4. Architecture-driven optimization of nanocarriers for pH-responsive drug delivery · 2026 · Related
  5. Empagliflozin in Heart Failure with a Preserved Ejection Fraction · Stefan D. Anker · 2021 · 4865 citations · Cited by this paper
  6. From meal to medicine: exploring the roots and consequences of drug-food effects · 2026 · Related
  7. Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis · Gautam Radhakrishna Desiraju · 1995 · 4862 citations · Cited by this paper
  8. Antimicrobial and thermostabilizing properties of a novel surfactant on different bacterial species · 2026 · Related
  9. From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus · Ralph Anthony DeFronzo · 2009 · 3064 citations · Cited by this paper
  10. Mechanistic insights into the self-assembly and cellular uptake of thermoresponsive pNIPAM-grafted hyaluronic acid nanogels · 2025 · Related
  11. The mechanisms of action of metformin · Graham Rena · 2017 · 2317 citations · Cited by this paper
  12. Exploring anti-integrin α6 antibody and transferrin-decorated dual drug-loaded liposomes as a promising nanoplatform for glioblastoma therapy: a preclinical approach · 2025 · Related
  13. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) · Melanie J. Davies · 2022 · 2106 citations · Cited by this paper
  14. Necessity of considering sex factors in the clinical application of transdermal formulations · 2025 · Related
  15. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy · Roy M. Gulick · 1997 · 1921 citations · Cited by this paper
  16. Immune-chemo combination therapy using doxorubicin/viral epitope Pluronic nanoparticles · 2025 · Related
  17. A strategy to reduce cardiovascular disease by more than 80% · Nicholas Wald · 2003 · 1574 citations · Cited by this paper
  18. Unveiling the treatment potential of irinotecan-loaded biopolymeric nanocarrier system in skin cancer via targeting CD44 receptors · 2025 · Related
  19. Pharmaceutical Cocrystals and Their Physicochemical Properties · N. Schultheiss · 2009 · 1501 citations · Cited by this paper
  20. Advances in pharmaceutical formulation technologies for thermostable vaccine platforms considering patient-centered design · 2025 · Related
  21. Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus · Hiddo J.L. Heerspink · 2016 · 1379 citations · Cited by this paper
  22. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? · �rn Almarsson · 2004 · 1080 citations · Cited by this paper
  23. In Vitro Dissolution Profile Comparison—Statistics and Analysis of the Similarity Factor, f2 · Vinod P. Shah · 1998 · 690 citations · Cited by this paper
  24. Creating Cocrystals: A Review of Pharmaceutical Cocrystal Preparation Routes and Applications · Maryam Karimi-Jafari · 2018 · 668 citations · Cited by this paper
  25. Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction · Carlos G. Santos‐Gallego · 2020 · 548 citations · Cited by this paper
  26. The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus · Volker Vallon · 2014 · 354 citations · Cited by this paper
  27. Improving Mechanical Properties of Caffeine and Methyl Gallate Crystals by Cocrystallization · Changquan Calvin Sun · 2008 · 341 citations · Cited by this paper
  28. Empagliflozin compared with glimepiride in metformin‐treated patients with type 2 diabetes: 208‐week data from a masked randomized controlled trial · Martin Ridderstråle · 2018 · 58 citations · Cited by this paper
  29. Empagliflozin improves quality of life in nondiabetic HFrEF patients. Sub-analysis of the EMPATROPISM trial · Juan Antonio Requena-Ibáñez · 2022 · 52 citations · Cited by this paper
  30. Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease · Anubha Agarwal · 2024 · 49 citations · Cited by this paper
  31. Spherical Cocrystallization—An Enabling Technology for the Development of High Dose Direct Compression Tablets of Poorly Soluble Drugs · Hongbo Chen · 2019 · 38 citations · Cited by this paper
  32. Improving the Solubility, Dissolution, and Bioavailability of Metronidazole via Cocrystallization with Ethyl Gallate · Jinhui Li · 2021 · 31 citations · Cited by this paper
  33. Manufacture and characterization of two distinct quasi-polymorphs of empagliflozin · Paul Kim · 2020 · 10 citations · Cited by this paper
  34. Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects · Xu Jiang · 2023 · 6 citations · Cited by this paper
  35. Pharmacokinetic Comparison Between a Fixed‐Dose Combination of Empagliflozin L‐Proline/Metformin and Empagliflozin/Metformin in Healthy Korean Subjects · HyunJoon Lee · 2023 · 2 citations · Cited by this paper
  36. Untitled · Cited by this paper

Source: OpenAlex (CC0)